Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-25 @ 1:43 AM
NCT ID:
NCT02675894
Eligibility Criteria:
Inclusion Criteria: all conditions have to be fulfilled.
* Diagnosed with HCC (1\~5cm) according to AASLD guideline or LI-RADS on MDCT or liver MRI within 60 days before RFA
* liver metastasis histologically confirmed or characteristic findings on cross-sectional imaging
* signed informed consent
* treatment naive index tumor (no history of local treatment for an index tumor)
Exclusion Criteria:
* more than three tumors in a patients
* tumor size larger than 5cm
* tumor attaches to central portal vein or hepatic vein
* Child-Pugh classification C
* uncorrected coagulopathy
* presence of extrahepatic metastases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT02675894
Study Brief:
Protocol Section:
NCT02675894